180 Life Sciences Corp.

1.58
0.00 (0.00%)
At close: Jan 17, 2025, 3:59 PM
1.54
-2.53%
After-hours Jan 17, 2025, 07:48 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -19.94M -38.73M -20.32M -10.88M -25.39M -14.50M 123.76K
Depreciation & Amortization 105.67K 109.00K 109.95K 125.33K 72.24K 23.08K n/a
Stock-Based Compensation 2.28M 2.97M 5.00M 1.12M 13.30M 4.60M n/a
Other Working Capital -300.51K 1.51M -3.08M 105.35K 140.99K -117.52K 53.56K
Other Non-Cash Items 8.99M 22.08M 6.82M 3.46M 5.68M 6.07M -567.56K
Deferred Income Tax -2.35M -942.75K -24.80K -20.43K -9.50K n/a n/a
Change in Working Capital -14.10K 2.72M -8.81M 2.33M 3.04M -117.52K -53.56K
Operating Cash Flow -10.92M -12.13M -19.37M -3.87M -3.32M -3.92M -497.36K
Capital Expenditures 3.00 n/a n/a n/a -144.40K -30.83K n/a
Acquisitions n/a n/a n/a 3.01M 86.08K n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a 10.28M n/a n/a n/a
Other Investing Acitivies n/a n/a n/a 1.20M -649.83K -60.00K -115.92M
Investing Cash Flow n/a n/a n/a 14.49M -708.15K -90.83K -115.92M
Debt Repayment -288.07K -530.14K 800.85K 319.43K 2.69M n/a n/a
Common Stock Repurchased n/a -1.01M n/a -9.01M n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 196.47K 11.40M -2.06M -119.36K 1.26M 4.77M 116.78M
Financial Cash Flow 5.91M 10.87M 25.41M -8.73M 3.94M 4.77M 116.78M
Net Cash Flow -4.99M -1.25M 6.12M 2.03M -483.82K -157.51K 361.14K
Free Cash Flow -10.92M -12.13M -19.37M -3.87M -3.46M -3.95M -497.36K

Create Price Alert on ATNF

Your price alert will notify you when the stock price is above 1.58.

Add to Watchlist